THC
—
CBD
0.2%
Kaleidoscope is a hybrid from Gage Green Group, a breeder known for experimental, small-batch, boundary-pushing genetics.
No effect, terpene, flavor or medical-use data specific to Kaleidoscope has been published yet, so we don't guess. For what hybrid strains usually do, see the effects guide.
About Kaleidoscope
Gage Green Group has built its reputation on unusual, boundary-pushing genetics, and Kaleidoscope carries that spirit through its name alone, evoking shifting colors and shifting perspective rather than a single fixed trait. As a hybrid, it belongs to the broad middle ground between indica and sativa that most modern breeders use for crosses drawing on both parent lines. The breeder's catalog tends to favor experimental, small-batch crosses over mainstream, high-volume releases, and a name this abstract fits comfortably alongside that approach. Where some seed banks lean on a clean THC number or a documented lineage to sell a cultivar, Gage Green Group's releases often ask buyers to trust the breeder's track record and the name itself first. Kaleidoscope, for now, is exactly that kind of listing: a Gage Green Group hybrid defined by its identity rather than its spec sheet.
Where to Buy Seeds
We may earn a commission from purchases made through these links.
Frequently Asked Questions about Kaleidoscope
Is Kaleidoscope an Indica, Sativa, or Hybrid?
Kaleidoscope is classified as a hybrid cannabis strain.
What cannabinoid content is reported for Kaleidoscope?
Kaleidoscope: 0.2% CBD reported in our data. The THC figure, when present, is the upper end of the reported range, not a typical measured dose. Potency can vary across harvests, phenotypes, and growing conditions.